Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells

Xenotransplantation

Volumn 5, Issue 2, 1998, Pages 132-145

  Kumagai Braesch, Makiko ^a   Satake, Masahiro ^a   Qian, Yunjian ^a   Holgersson, Jan ^a   Möller, Erna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ADCC; Cyclosporine A; Fetal porcine islet cells; Human NK cells; In vitro activation; Limiting dilution; Xenogeneic porcine cells

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CYCLOSPORIN A; INTERLEUKIN 2;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CONTROLLED STUDY; FETUS CELL; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; SWINE; XENOTRANSPLANTATION;

EID: 0031959934     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1998.tb00019.x     Document Type: Article

References (43)

1. SATAKE M, KORSGREN O, RIDDERSTAD A, KARLSSON-PARRA A, WALLGREN A-C, MÖLLER E. Immunological characteristics of Islet cell xenotransplantation in human and rodents. Immunol Rev 1994; 141:191.
2. GALILI U, MACHER BA, BUETHLER J, SHOHET S. Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1-3)-linked galactose residues. J Exp Med 1985; 162:573.
3. WOOD C, KABAT EA, MURPHY LA, GOLDSTEIN IJ. Immunochemical studies of the combining sites of the two isolectins, A4 and B4, isolated from Bandeiraea simplifolia. Arch Biochem Biophys 1979; 198:1-11.
4. SANDRIN MS, MCKENZIE IF. Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. [Review]. Immunol Rev 1994; 141:169.
5. SATAKE M, KUMAGAI-BRAESCH M, KURSGREN O, ANDERSSON A, MÖLLER E. Characterization of humoral human anti-porcine xenoreactivity. Clin Transplant 1993; 7:281.
6. ROSS JR, KIRK AD, IBRAHIM SE, HOWELL DN, BALDWIN WM, SANFILIPPO FP. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts-predominance of IgM and IgG2. Transplantation 1993; 55:1144.
7. GREENWOOD J, CLARK M, WALDMANN H. Structural motifs involved in human IgG antibody effector functions. Eur J Immunol 1993; 23:1098.
8. WALLGREN AC, LARLSSON-PARRA A, KURSGREN O. The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte. Transplantation 1995; 60:594.
9. LEVENTHAL JR, DALMASSO AP, CRANWELL JL, MANIVEL CJ, BOLMAN RM, MATAS AJ. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55:857.
10. BLAKELY ML, VAN DER WERF WJ, BERNDT MC, DALMASSO AP, BACH FH, HANCOCK WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58:1059.
11. BACH FH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC. Delayed xenograft rejection. Immunol Today 1996; 17:379.
12. THOMAS FT, MARCHAN W, CAROBBI A, ARANEDA D, PRYOR W, THOMAS J. Immunobiology of the xenograft response: Xenograft rejection in the immunodeficient rodents. Transplant Proc 1991; 23:208.
13. KARLSSON-PARRA A, RIDDERSTAD A, WALLGREN AC, MÖLLER E, LJUNGGREN HG, KURSGREN O. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation 1996; 61:1313.
14. INVERARDI L, PARDI R. Early events in cell mediated recognition of vascularized xenografts: Cooperative interactions between selected lymphocyte subsets and natural antibodies. Immunol Rev 1994; 141:71.
15. RAVETCH JV, KINET JP. Fc receptors. Annu Rev Immunol 1991; 9:457.
16. TRINCHIERI G, PERUSSIA B. Human Natural Killer cells: biologic and pathologic aspects. Lab Invest 1984; 50:489.
17. SATAKE M, KUMAGAI-BRAESCH M, KAWAGISHI N, TIBELL A, GROTH C-G, MÖLLER E. Kinetics and character of xenoantibody formation in diabetic patients transplanted with fetal porcine islet cell clusters. Xenotransplantation 1994; 1:24.
18. SATAKE M, KAWAGISHI N, MÖLLER E. Direct activation of human responder T cells by porcine stimulator cells leads to T cell proliferation and cytotoxic T cell development. Xenotransplantation 1996; 3:198.
19. CHAN D, AUCHINCLOSS H. Human anti-pig cell-mediated cytotoxicity in vitro involves non-T as well as T cell components. Xenotransplantation 1996; 3:158.
20. SEEBACH J, YAMADA K, MCMORROW I, SACHS D, DERSIMONIAN H. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996;3:188.
21. LJUNGGREN HG, KÄRRE K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 1990; 11:237.
22. NAUME B, ESPEVIK T. Immunoregulatory effect of cytokines on natural killer cells. Scand J Immunol 1994; 40:128.
23. KURSGREN O, SANDLER S, LANDSTRÖM A, JANSSON L, ANDERSSON A. Large-scale production of fetal porcine pancreatic islet like clusters. Transplantation 1988; 45: 509.
24. JOHANSSON BORG A, KUMAGAI-BRAESCH M., MÖLLER E. Effect of DSG on xenogeneic immune reactivity with special emphasis on human anti-pig cellular reactions in vitro. Xenotransplantation 1996; 3:171.
25. JOHANSSON BORG A, KUMAGAI-BRAESCH M, MÖLLER E. 15-Deoxyspergualin inhibits interleukin-6 production in in vitro stimulated human lymphocytes. Transplant Immunol 1996; 4:133.
26. LIU J, QIAN Y, HOLGERSSON J. Removal of xenoreactive human anti-porcine antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Galα1,3Gal epitopes. Transplantation 1997; 63:1673.
27. KUMAGAI-BRAESCH M, SATAKE M, KORSGREN O, ANDERSSON A, MÖLLER E. Characterization of cellular human anti-porcine xenoreactivity. Clin Transplant 1993; 7:273.
28. FAZEKAS DE ST GROTH S. The evaluation of limiting dilution assays. J Immunol Method 1982; 49:R11.
29. KUMAGAI-BRAESCH M, JOHANSSON-BORG A, SATAKE M, MÖLLER E. Characterization of direct and indirect activation of human T cells by allogeneic and xenogeneic porcine cell/peptides. Xenotransplantation 1997; 4:85.
30. KIRK AD, LI RA, KINCH MS, ABERNETHY KA, DOYLE C, BOLLINGER RR. The human anti-porcine cellular repertoire: In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993; 55:924.
31. KARRE K, LJUNGGREN KG, PIONTEK G, KIESSLING R. Selective rejection of H-2-deficient lymphoma variants suggests alternative defence strategy. Nature 1986; 319:675.
32. YOKOYAMA WM. Natural killer cell receptors. Curr Opin Immunol 1995; 7:110.
33. RAULET DH. Recognition events that inhibit and activate natural killer cells. Curr Opin Immunol 1996; 8:372.
34. COLONNA M, SAMARIDIS J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995; 268:405.
35. GUMPERZ JE, LITWIN V, PHILLIPS JH, LANIER LL, PARHAM P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 1995; 181:1133.
36. PENDE D, BIASSONI R, CANTONI C, VERDIANI S, FOLCO M, DI DANATO C, ACCAME L, BOTTINO C, MORETTA A, MORETTA L. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors which is characterized by three Ig-like domains and is expressed as a 140 kD disulphide-linked dimer. J Exp Med 1996; 184:505.
37. MORETTA A, VITALE M, SIVORI S, BOTTINO C, MORELLI L, AUGUGLIARO R, BARBARESI M, PENDO D, CICCONE E, LOPEZ-BOTET M, MORETTA L. Human natural killer cell receptors for HLA-classI molecules: Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 1994; 180:545.
38. TSUDO M, GOLDMAN CK, BONGIOVANNI KF, CHAN WC, WINTON EF, YAGITA M, GRIMM EA, WALDMANN TA. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells. Proc Natl Acad Sci USA 1987; 84:5394.
39. FLANAGAN WM, CORTHESY B, BRAM RJ, CRABTREE GR. Nuclear association of a T cell transcription factor blocked by FK506 and cyclosporin A. Nature 1991; 351:803.
40. ARAMBURU J, AZZONI L, RAO A, PERUSSIA B. Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: Regulation upon CD16 ligand binding. J Exp Med 1995; 182:801.
41. SATAKE M, KAWAGISHI N, RYDBERG L, SAMUELSSON BE, TIBELL A, GROTH C-G, MÖLLER E. Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters. Main antibody reactivity against a-linked galactose-containing groups. Xenotransplantation 1994; 1:89.
42. RYDBERG L, CAIRNS TDH, GROTH C-G, GUSTAVSSON ML, KARLSSON EC, MÖLLER E, SATAKE M, TIBELLA, SAMUELSSON BE. Specificities of human IgM and IgG anti-carbohydrate antibodies found in the sera of diabetic patients grafted with fetal pig cells. Xenotransplantation 1994; 1:69.
43. GALILI U, TIBELL A, SAMUELSSON B, RYDBERG L, GROTH CG. Increased anti-gal activity in diabetic patients transplanted with fetal porcine islet cell clusters. Transplantation 1995; 59:1549.